November 17, 2021

Sanyou Biopharmaceuticals completes series B financing and secures its leading role in innovative antibody drug discovery

Established in 2015, Sanyou Bio focuses on R&D of innovative antibody drugs. The Company’s vision is to improve quality of life with innovative antibody drugs, and their mission is to empower the industry to develop any innovative antibody drug.  Sanyou Bio have been continuously building a world-leading high-throughput integrated R&D platform for innovative antibody drugs, collecting technical resources to establish the largest antibody library in the world. While providing leading services, Sanyou Bio have made every effort to collaborate with their partners to develop innovative antibody drugs to meet the patients’ need.

After 6 years of persistent endeavor, Sanyou Bio has established a state-of-the-art integrated R&D platform for innovative antibody drug discovery, provided hundreds of unique R&D solutions and technical services for innovative antibody drug discovery projects…

Read full article here: